The median period from the end of treatment to diagnosis of HCC was 35 (range 10–57) months in the PEG-IFN/RBV group and 22 (range 4–67) months in the DCV/ASV groups (P = 0.54). This evidence concerns the gene IFNA1 and hepatocellular carcinoma.